Loading clinical trials...
Loading clinical trials...
Phase I/II Randomized Cross-over Study of Hypertonic Saline on Airway Inflammatory Response to Inhaled Wood Smoke
Conditions
Interventions
5% Hypertonic Saline
No treatment
Locations
1
United States
Center for Environmental Medicine, Asthma and Lung Biology at UNC Chapel Hill
Chapel Hill, North Carolina, United States
Start Date
August 1, 2019
Primary Completion Date
September 12, 2024
Completion Date
September 12, 2024
Last Updated
August 8, 2025
NCT07116460
NCT02767973
NCT03861390
NCT00604578
NCT00455377
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions